Liver metastases inhibit immunotherapy efficacy
- PMID: 33442002
- DOI: 10.1038/s41591-020-01190-9
Liver metastases inhibit immunotherapy efficacy
Comment on
-
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.Nat Med. 2021 Jan;27(1):152-164. doi: 10.1038/s41591-020-1131-x. Epub 2021 Jan 4. Nat Med. 2021. PMID: 33398162 Free PMC article.
References
-
- Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Cell 168, 707–723 (2017). - DOI
-
- Yu, J. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1131-x (2020).
-
- Forrester, J. V., Xu, H., Lambe, T. & Cornall, R. Mucosal Immunol. 1, 372–381 (2008). - DOI
-
- Medina-Echeverz, J., Eggert, T., Han, M. & Greten, T. F. Cancer Immunol. Immunother. 64, 931–940 (2015). - DOI
-
- Qian, B. Z. & Pollard, J. W. Cell 141, 39–51 (2010). - DOI
Publication types
MeSH terms
Substances
Grants and funding
- DR52-18/Damon Runyon Cancer Research Foundation (Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation)/International
- R37CA230636/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)/International
- 1R01CA251155/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)/International
- 2T32AI078892/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
